"" Intel Stock Falls Amid Analyst Pressure
Shares of Intel Corporation plummeted 6.1% in morning trading today, following a downgrade by UBS to $112 from $121. The move reinforced concerns that the stock's near-term upside is constrained, despite Intel's long-term ambitions in foundry and AI.
The primary weight on the stock remains the dilution fallout from Intel's $20 billion common stock offering, which closed on August 12 at $95 per share. Bank of America has estimated that the share issuance will reduce earnings per share by roughly 4% to 5% once the higher share count flows into forward estimates.
The broader Nasdaq Composite is down 1.2% today, creating an unfavorable backdrop for high-beta semiconductor names like Intel. The positive catalyst from Monday – Nvidia's regulatory filing disclosing a roughly $30 billion stake in Intel – has largely been absorbed by the market, leaving the dilution overhang and today's analyst action as the dominant drivers.
As a result, Intel shares have fallen to $97.14, well below the $99.31 open and sitting near the day's low of $97.10. While the stock has made significant gains over the past year, the recent sell-off reflects the ongoing challenges facing the company's turnaround narrative.
Key Facts:
- Intel Corporation shares fell 6.1% in morning trading today
- UBS reduced its price target to $112 from $121
- The company's $20 billion common stock offering has reduced earnings per share by roughly 4% to 5%
- The broader Nasdaq Composite is down 1.2% today
- Intel shares have fallen to $97.14, well below the $99.31 open